US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist

2.8900
-0.0600-2.03%

Close Nov 26 16:00 ET

2.8900
0.00000.00%

Post 20:01 ET

42.63MMarket Cap0.85P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-65.18%-8.51M

11.42%-8.48M

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

Net income from continuing operations

-84.64%-12.16M

6.48%-9.41M

-11.15%-6.25M

-22.59%-28.45M

37.78%-6.19M

30.39%-6.58M

-18.66%-10.06M

-220.39%-5.62M

68.35%-23.21M

14.04%-9.95M

Operating gains losses

----

-928.59%-12.64M

39.30%280K

Depreciation and amortization

----

--0

----

-33.94%72K

-696.15%-155K

Change In working capital

500.70%3.42M

267.35%656K

-172.47%-1.94M

-97.36%60K

-84.91%595K

-40.11%569K

59.34%-392K

56.87%-712K

-52.32%2.28M

429.05%3.94M

-Change in receivables

415.65%2.54M

-490.34%-2.83M

-547.00%-1.29M

-96.39%405K

-119.35%-612K

394.61%492K

213.85%725K

-102.51%-200K

45.41%11.21M

29.22%3.16M

-Change in inventory

----

--0

----

-14.16%97K

--0

-Change in payables and accrued expense

1,072.73%903K

415.22%3.52M

-19.53%-612K

93.56%-559K

-60.61%993K

-25.96%77K

34.53%-1.12M

94.67%-512K

-224.52%-8.68M

188.71%2.52M

-Change in other current liabilities

---22K

---35K

---34K

161.32%214K

--214K

--0

71.20%-349K

--0

Cash from discontinued investing activities

Operating cash flow

-65.18%-8.51M

11.42%-8.48M

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

Investing cash flow

Cash flow from continuing investing activities

-4.82M

19.02M

-171.38%-3.57M

-466.08%-57.35M

-6,235,500.00%-62.35M

-68.26%5M

1,425.51%15.67M

Net business purchase and sale

--0

-68.09%5M

--0

-68.26%5M

--15.67M

--1K

Net investment purchase and sale

---4.82M

--19.02M

---3.57M

---62.35M

--0

----

Cash from discontinued investing activities

Investing cash flow

---4.82M

--19.02M

-171.38%-3.57M

-466.08%-57.35M

-6,235,500.00%-62.35M

--0

-68.26%5M

1,425.51%15.67M

--1K

Financing cash flow

Cash flow from continuing financing activities

95.74%-2K

40.00%-3K

98.16%-4K

4,884.51%82.39M

39,641.83%82.66M

-80.77%-47K

91.80%-5K

-114.16%-217K

-95.84%1.65M

647.37%208K

Net common stock issuance

--0

5,534.08%82.82M

8,266,600.00%82.67M

--0

-89.98%156K

-98.07%1.47M

96.55%-1K

Net preferred stock issuance

--0

-270.62%-360K

--0

---360K

--211K

Proceeds from stock option exercised by employees

----

40.00%-3K

69.23%-4K

-139.29%-67K

----

---5K

---13K

-105.36%-28K

----

Cash from discontinued financing activities

Financing cash flow

95.74%-2K

40.00%-3K

98.16%-4K

4,884.51%82.39M

39,641.83%82.66M

-80.77%-47K

91.80%-5K

-114.16%-217K

-95.84%1.65M

647.37%208K

Net cash flow

Beginning cash position

43.25%29.66M

-36.86%19.12M

-0.97%30.67M

-27.72%30.98M

-56.43%15.5M

-51.65%20.7M

-40.74%30.28M

-27.72%30.98M

-26.64%42.86M

-32.76%35.58M

Current changes in cash

-156.51%-13.34M

209.99%10.54M

-1,562.59%-11.56M

97.47%-301K

429.68%15.17M

28.16%-5.2M

-15.60%-9.58M

-108.43%-695K

23.67%-11.88M

54.24%-4.6M

End cash Position

5.27%16.32M

43.25%29.66M

-36.86%19.12M

-0.97%30.67M

-56.43%15.5M

-51.65%20.7M

-40.74%30.28M

-27.72%30.98M

Free cash flow

-65.18%-8.51M

11.42%-8.48M

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-65.18%-8.51M	11.42%-8.48M	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M
Net income from continuing operations	-84.64%-12.16M	6.48%-9.41M	-11.15%-6.25M	-22.59%-28.45M	37.78%-6.19M	30.39%-6.58M	-18.66%-10.06M	-220.39%-5.62M	68.35%-23.21M	14.04%-9.95M
Operating gains losses	----	----	----	----	----	----	----	----	-928.59%-12.64M	39.30%280K
Depreciation and amortization	----	----	----	--0	----	----	----	----	-33.94%72K	-696.15%-155K
Change In working capital	500.70%3.42M	267.35%656K	-172.47%-1.94M	-97.36%60K	-84.91%595K	-40.11%569K	59.34%-392K	56.87%-712K	-52.32%2.28M	429.05%3.94M
-Change in receivables	415.65%2.54M	-490.34%-2.83M	-547.00%-1.29M	-96.39%405K	-119.35%-612K	394.61%492K	213.85%725K	-102.51%-200K	45.41%11.21M	29.22%3.16M
-Change in inventory	----	----	----	--0	----	----	----	----	-14.16%97K	--0
-Change in payables and accrued expense	1,072.73%903K	415.22%3.52M	-19.53%-612K	93.56%-559K	-60.61%993K	-25.96%77K	34.53%-1.12M	94.67%-512K	-224.52%-8.68M	188.71%2.52M
-Change in other current liabilities	---22K	---35K	---34K	161.32%214K	--214K	--0	--0	--0	71.20%-349K	--0
Cash from discontinued investing activities
Operating cash flow	-65.18%-8.51M	11.42%-8.48M	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M
Investing cash flow
Cash flow from continuing investing activities	-4.82M	19.02M	-171.38%-3.57M	-466.08%-57.35M	-6,235,500.00%-62.35M	0	0	-68.26%5M	1,425.51%15.67M	1K
Net business purchase and sale	--0	--0	--0	-68.09%5M	--0	--0	--0	-68.26%5M	--15.67M	--1K
Net investment purchase and sale	---4.82M	--19.02M	---3.57M	---62.35M	---62.35M	--0	--0	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	---4.82M	--19.02M	-171.38%-3.57M	-466.08%-57.35M	-6,235,500.00%-62.35M	--0	--0	-68.26%5M	1,425.51%15.67M	--1K
Financing cash flow
Cash flow from continuing financing activities	95.74%-2K	40.00%-3K	98.16%-4K	4,884.51%82.39M	39,641.83%82.66M	-80.77%-47K	91.80%-5K	-114.16%-217K	-95.84%1.65M	647.37%208K
Net common stock issuance	--0	--0	--0	5,534.08%82.82M	8,266,600.00%82.67M	--0	--0	-89.98%156K	-98.07%1.47M	96.55%-1K
Net preferred stock issuance	--0	--0	--0	-270.62%-360K	--0	--0	--0	---360K	--211K	--211K
Proceeds from stock option exercised by employees	----	40.00%-3K	69.23%-4K	-139.29%-67K	----	----	---5K	---13K	-105.36%-28K	----
Cash from discontinued financing activities
Financing cash flow	95.74%-2K	40.00%-3K	98.16%-4K	4,884.51%82.39M	39,641.83%82.66M	-80.77%-47K	91.80%-5K	-114.16%-217K	-95.84%1.65M	647.37%208K
Net cash flow
Beginning cash position	43.25%29.66M	-36.86%19.12M	-0.97%30.67M	-27.72%30.98M	-56.43%15.5M	-51.65%20.7M	-40.74%30.28M	-27.72%30.98M	-26.64%42.86M	-32.76%35.58M
Current changes in cash	-156.51%-13.34M	209.99%10.54M	-1,562.59%-11.56M	97.47%-301K	429.68%15.17M	28.16%-5.2M	-15.60%-9.58M	-108.43%-695K	23.67%-11.88M	54.24%-4.6M
End cash Position	5.27%16.32M	43.25%29.66M	-36.86%19.12M	-0.97%30.67M	-0.97%30.67M	-56.43%15.5M	-51.65%20.7M	-40.74%30.28M	-27.72%30.98M	-27.72%30.98M
Free cash flow	-65.18%-8.51M	11.42%-8.48M	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data